(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
2020-07-04
عنوان الدراسة
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients
داعم الدراسة
Novartis
دواء الدراسة
Ultibro breezhaler
رقم بروتوكول الدراسة
A3405 V01
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
4
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.